Fuller & Thaler Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29M | Buy |
1,263,772
+174
| +0% | +$4K | 0.11% | 231 |
|
|
2025
Q1 | $36.6M | Buy |
1,263,598
+130,672
| +12% | +$3.79M | 0.14% | 209 |
|
|
2024
Q4 | $42.1M | Sell |
1,132,926
-127,841
| -10% | -$4.75M | 0.16% | 201 |
|
|
2024
Q3 | $61.2M | Sell |
1,260,767
-12,051
| -0.9% | -$585K | 0.24% | 143 |
|
|
2024
Q2 | $50.9M | Sell |
1,272,818
-1,360
| -0.1% | -$54.4K | 0.22% | 144 |
|
|
2024
Q1 | $55.9M | Buy |
1,274,178
+1,161
| +0.1% | +$51K | 0.24% | 133 |
|
|
2023
Q4 | $78.7M | Sell |
1,273,017
-2,197
| -0.2% | -$136K | 0.4% | 96 |
|
|
2023
Q3 | $58.6M | Sell |
1,275,214
-4,281
| -0.3% | -$197K | 0.34% | 102 |
|
|
2023
Q2 | $73.5M | Buy |
1,279,495
+467,801
| +58% | +$26.9M | 0.42% | 87 |
|
|
2023
Q1 | $30.4M | Buy |
811,694
+311,629
| +62% | +$11.7M | 0.18% | 153 |
|
|
2022
Q4 | $14M | Sell |
500,065
-215,116
| -30% | -$6.03M | 0.09% | 185 |
|
|
2022
Q3 | $20.1M | Sell |
715,181
-11,335
| -2% | -$319K | 0.14% | 158 |
|
|
2022
Q2 | $25.3M | Buy |
726,516
+111,661
| +18% | +$3.88M | 0.17% | 158 |
|
|
2022
Q1 | $22.1M | Buy |
614,855
+3,393
| +0.6% | +$122K | 0.13% | 173 |
|
|
2021
Q4 | $14.2M | Buy |
611,462
+210,362
| +52% | +$4.9M | 0.08% | 201 |
|
|
2021
Q3 | $7.63M | Buy |
401,100
+1,655
| +0.4% | +$31.5K | 0.05% | 242 |
|
|
2021
Q2 | $8.05M | Buy |
399,445
+1,495
| +0.4% | +$30.1K | 0.05% | 240 |
|
|
2021
Q1 | $7.29M | Sell |
397,950
-148,394
| -27% | -$2.72M | 0.05% | 238 |
|
|
2020
Q4 | $11M | Sell |
546,344
-271,171
| -33% | -$5.45M | 0.1% | 190 |
|
|
2020
Q3 | $15.3M | Buy |
817,515
+2,386
| +0.3% | +$44.7K | 0.19% | 132 |
|
|
2020
Q2 | $18.3M | Buy |
+815,129
| New | +$18.3M | 0.24% | 115 |
|